首页> 美国卫生研究院文献>American Journal of Cancer Research >MicroRNAs-208b-3p 204-5p 129-2-3p and 3065-5p as predictive markers of oral leukoplakia that progress to cancer
【2h】

MicroRNAs-208b-3p 204-5p 129-2-3p and 3065-5p as predictive markers of oral leukoplakia that progress to cancer

机译:MicroRNAs-208b-3p204-5p129-2-3p和3065-5p作为发展为癌症的口腔白斑的预测标记

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Leukoplakia is the most common precursor lesion of oral squamous cell carcinoma (OSCC). Currently, the risk of progression to OSCC is assessed based on histopathologic examination alone. However, this method fails to identify the subset of microscopically innocuous leukoplakia that ultimately transforms to OSCC. The aim of this study was to determine if microRNAs (miRNAs) can be utilized to identify non- and low-grade dysplastic oral lesions at risk for cancer progression. A retrospective study of genome-wide miRNA expression level analyses was performed in the training cohort (n=20) using deep sequencing formalin-fixed paraffin embedded incisional biopsy tissues from patients with oral leukoplakic lesions diagnosed with non- or low-grade dysplasia and known clinical outcome. The promising miRNA candidates were then evaluated in the validation cohort (n=80) using quantitative real-time PCR (qRT-PCR). Four promising miRNAs-208b-3p, 204-5p, 129-2-3p and 3065-5p were identified. Combining these four miRNAs as a panel with age and histologic diagnosis (p<0.004), our final model had a predictive value for the area under the receiver operating characteristic (ROC) curve (AUC) of 0.792, sensitivity of 76.9% and specificity of 73.7% to accurately identify non- and low-grade dysplastic lesions at risk of cancer progression, which is a significant improvement over histopathologic examination alone (AUC of 0.645). While further investigation is needed, discovery of predictive markers that can accurately identify histologically innocuous oral lesions at high risk for progression to OSSC will significantly improve clinical outcome by means of early intervention.
机译:白斑是口腔鳞状细胞癌(OSCC)最常见的前体病变。目前,仅根据组织病理学检查就可以评估发展为OSCC的风险。但是,该方法无法识别最终转化为OSCC的无显微镜下白斑的子集。这项研究的目的是确定是否可以利用microRNA(miRNA)来识别处于癌症发展风险的非高度和低度增生性口腔病变。在训练队列(n = 20)中,使用福尔马林固定石蜡包埋的切开活检组织深度测序对来自训练有诊断为非低度增生和低度增生的口腔白斑病变患者的组织进行了全基因组miRNA表达水平分析的回​​顾性研究临床结果。然后使用定量实时PCR(qRT-PCR)在验证队列(n = 80)中评估有希望的miRNA候选物。确定了四个有前途的miRNAs-208b-3p,204-5p,129-2-3p和3065-5p。结合年龄和组织学诊断(p <0.004)作为面板的这四个miRNA,我们的最终模型对受试者工作特征(ROC)曲线(AUC)下面积的预测值为0.792,敏感性为76.9%,特异性为以73.7%的比率准确识别出存在癌症进展风险的非和低度增生性病变,这比仅组织病理学检查(AUC为0.645)有显着改善。尽管需要进一步研究,但发现预测标记物可以通过早期干预显着改善临床结局,这些预测标记物可以准确识别出在发展为OSSC的高风险中组织学上无害的口腔病变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号